Lipid Lowering Drugs+ Fibrinolytic Flashcards
Lipid lowering drugs name ?
Predominantly cholesterol lowering agents
HMG-CoA Reductase inhibitor (Statin)
AtOR-rosu-lo-flu-sim-pita—-vastatin
Cholesterol absorption inhibitor
eztimibe
Bile acid binding resin
colestipol
niacin-V-B3
Predominately TG lowering agents
Fibrates/Fibric acid derivatives - FenoFibrate
Highly polyunsaturated long chain n=3 fatty acids
Eicosapentanoic acid
Docosahexanoic acid
page-446
Mechanism of Atorvastatin
Inhibit HMG-CoA REDUCTASE
=block the rate limiting steps of cholesterol synthesis
=dec cholesterol synthesis
=dec VLDL LDL
Increase LDL receptor
=inc cell surface LDL receptor
=inc binding of LDL WITH ITS RECEPTOR
=inc internationalization
=inc catabolism of LDL
=dec plasma cholesterol
447
Indication of atorvastatin ?
- Hyperlipidemia
- Dyslipidemia
- After acute coronary syndrome
447
Atorvastatin in Heart disease ?
- dec LDL
- inc stability of atherosclerotic lesion
- after acute coronary syndrome
447
A/E of atorvastatin ?
- Myopathy
- Myalgia
- Myositis
- Rhabdomyolysis
- Biochemical abnormalities in LFT
- Inc bleeding tendency
448 page
Contraindications of Atorvastatin ?
- Nursing child
- Preganancy
- Children
- Teenegers
Mechanism of Fenofibrate ?
- Via LPL = inc lipolysis of TG
- dec VLDL
- dec TG
- Stimulate PPAR-Alpha = via LPL = Via LPL = inc lipolysis of TG
LPL= Lipoprotein Lipase
PPAR= Peroxisome Proliferator Activated Recepto
Indication of fenofibrate ?
- HyperTriGlyCeridamias
- DysBetaLipoProteinema
448
Contraindication of fenofibrate ?
- Preganancy
- Renal f
- Hepatic f
- Lactation
448
A/E of fenofibrate ?
- Myopathy
- Myalgia
- Myositis
- inc risk of bleeding
- inc risk of gall stone formation
- GIT abnormalities
448
which one is mostly used ?
fenofibrate
12-2-2025
9.40PM
Fibrinolytic / thrombolytic drugs name ?
streptokinase
urokinase
alte-plase
rete-plase
tenecte-plase
can plasmin be act as fibrinolytic ?
440
no
antiplasmin in plasma will inhibt it
M/A of streptokinase ?
S + plasminogen
S-P complex
conversion of plasminogen ———– plasmin
degradation of – fibrinogen + fibrin + factor - 5
7
dissolution of clot inthe embolus / thrombus
re-opening of blood vessel
inc blood flow
releirf MI
441
Indication of streptokinase ?
acute MI
DVT ‘
PE
PVD
arterio-venous shunt
A/E of streptokinase ?
bleeding disorder
hypersensitivity
N-V
Multiple micro-emboli